SEI Medical PCL (BKK:SEI)

SEI Medical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	494.42	443.98	393.57	320.55	375.73	377.68
Other Revenue	-	-	-	-	2.47	-
Revenue	494.42	443.98	393.57	320.55	378.2	377.68
Revenue Growth (YoY)	27.48%	12.81%	22.78%	-15.24%	0.14%	7.93%
Cost of Revenue	324.56	289.66	277.26	219.11	266.41	247.74
Gross Profit	169.87	154.32	116.31	101.44	111.79	129.94
Selling, General & Admin	93.01	89.11	86.38	78.17	61.84	66.73
Other Operating Expenses	-0.49	-	-	-	25.29	21.71
Operating Expenses	92.52	89.11	86.38	78.17	87.13	88.43
Operating Income	77.34	65.21	29.93	23.27	24.66	41.51
Interest Expense	-2.57	-3.34	-3.29	-2.78	-3.14	-2.98
Interest & Investment Income	2.13	2.31	0.82	0.04	0.01	0.01
Currency Exchange Gain (Loss)	-	-	-	-	-1.42	0.12
Other Non Operating Income (Expenses)	0.05	0.05	0.01	0.28	-	0
EBT Excluding Unusual Items	76.94	64.23	27.48	20.81	20.1	38.67
Gain (Loss) on Sale of Assets	1.07	1.07	0.01	1.77	1.68	0.52
Asset Writedown	-	-	-	-	-0.01	-
Other Unusual Items	-	-	-	-	-	-0.01
Pretax Income	78.01	65.3	27.49	22.59	21.78	39.17
Income Tax Expense	14.46	11.88	5.62	4.72	6.34	10.37
Net Income	63.55	53.42	21.87	17.86	15.44	28.79
Net Income to Common	63.55	53.42	21.87	17.86	15.44	28.79
Net Income Growth	136.90%	144.26%	22.43%	15.73%	-46.39%	25.53%
Shares Outstanding (Basic)	159	134	120	100	12	12
Shares Outstanding (Diluted)	159	134	120	100	12	12
Shares Change (YoY)	32.67%	12.09%	19.48%	735.07%	-	-
EPS (Basic)	0.40	0.40	0.18	0.18	1.29	2.40
EPS (Diluted)	0.40	0.40	0.18	0.18	1.29	2.40
EPS Growth	78.56%	117.91%	2.47%	-86.14%	-46.39%	-
Free Cash Flow	104.12	39.64	-29.95	34.55	-	-
Free Cash Flow Per Share	0.65	0.29	-0.25	0.34	-	-
Dividend Per Share	0.120	0.120	-	41.670	-	-
Gross Margin	34.36%	34.76%	29.55%	31.65%	29.56%	34.41%
Operating Margin	15.64%	14.69%	7.61%	7.26%	6.52%	10.99%
Profit Margin	12.85%	12.03%	5.56%	5.57%	4.08%	7.62%
Free Cash Flow Margin	21.06%	8.93%	-7.61%	10.78%	-	-
EBITDA	88.24	76.04	41.81	36.58	-	46.39
EBITDA Margin	17.85%	17.13%	10.62%	11.41%	-	12.28%
D&A For EBITDA	10.89	10.82	11.87	13.31	-	4.88
EBIT	77.34	65.21	29.93	23.27	24.66	41.51
EBIT Margin	15.64%	14.69%	7.61%	7.26%	6.52%	10.99%
Effective Tax Rate	18.53%	18.19%	20.43%	20.91%	29.12%	26.49%
Revenue as Reported	494.42	443.98	393.57	320.55	379.9	378.33
Advertising Expenses	-	-	-	-	0.7	1.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.